Bacterial inhibition of fungal growth and pathogenicity

References

• Tomita K, Nishio M, Saitoh K, Yamamoto H, Hoshino Y, Ohkuma H, Konishi M, Miyaki T, Oki T. Pradimicins A, B and C: new antifungal antibiotics I. Taxonomy, production, isolation and physico-chemical properties. J Antibiot 1990; 43 (7): 755–62.
   Google Scholar
• Walsh TJ, Gin i N. Pradimicins: a novel class of broad-spec-trum antifungal compounds. Eur J Clin Microbiol Infect Dis 1997; 16 (1): 93–7.
   Web of Science ®Google Scholar
• Trani A, Kettenring J, Ripamonti F, Goldstein B, Ciabatti R. Chemical modifications of the antibiotic, purpuromycin. Farmaco 1993; 48 (5): 637–51.
   Google Scholar
• Cooper R, Truumees I, Gunnarsson I, Loebenberg D, Ho-ran A, Marquez J, Patel M, Gullo V, Puar M, Das P, et al. Sch 42137, a novel antifungal antibiotic from an Actinoplanes sp. Fermentation, isolation, structure and bio-logical properties [published erratum appears in J Antibiot Aug; 45(8): C–3]. J Antibiot 1992; 45 (4): 444–53.
   Google Scholar
• Lysenkova LN, Olkhovatova OL, Malkina ND. Formation of a new polyene antibiotic octamycin by a culture of Actinoplanes ianthinogenes subsp. octamycini. Antibiotiki 1986; 31(10): 741–3.
   Google Scholar
• Axelrood PE, Clarke AM, Radley R, Zemcov SJ. Douglas-fir root-associated microorganisms with inhibitory activity towards fungal plant pathogens and human bacterial patho-gens. Can J Microbiol 1996; 42 (7): 690–700.
   Web of Science ®Google Scholar
• Nair MG, Mishra SK, Putnam AR, Pandey RC. Antifungal anthracycline antibiotics, spartanamycins A and B from Micromonospora spp. J Antibiot 1992; 45 (11): 1738–45.
   Web of Science ®Google Scholar
• Wu RY, Yang LM, Yokoi T, Lee KH. Neihumicin, a new cytotoxic antibiotic from Micromonospora neihuensis. I. The producing organism, fermentation, isolation and biological properties. J Antibiot 1988; 41(4): 481–7.
   Google Scholar
• Cooper R, Horan AC, Gentile F, Gullo V, Loebenberg D, Marquez J, Patel M, Puar MS, Truumees I. Sch 37137, a novel antifungal compound produced by a Micromonospora sp. Taxonomy, fermentation, isolation, structure and biolog-ical properties. J Antibiot 1988; 41(1): 13–9.
   Google Scholar
• Nishizawa N, Kondo Y, Koyama M, Omoto S, Iwata M, Tsurouka T, Inouye S. Studies on a new nucleotide antibi-otic, dapiramicin. II. Isolation, physico-chemical and biolog-ical characterisation. J Antibiot 1984; 37 (1): 1–5.
   Google Scholar
• Marquez JA, Horan AC, Kalyanpur M, Lee BK, Loeben-berg D, Miller GH, Patel M, Waitz JA. The hazimicins, a new class of antibiotics. Taxonomy, fermentation, isolation, characterisation and biological properties. J Antibiot 1983; 36 (9): 1101–8.
   Google Scholar
• Shiomi K, Linuma H, Naganawa H, Hameda M, Hattori S, Nakamura H, Takeuchi T, Litaka Y. New antibiotic pro-duced by Micromonospora globosa. J Antibiot 1990; 43 (8): 1000–5.
   PubMed Web of Science ®Google Scholar
• Gold W, Stout HA, Pahano JF, Donovick R. Amphotericin A and B, antifungal antibiotics produced by a Strepto-mycete. Antibiot Annual 1955–56: 579.
   Google Scholar
• Hazen EL, Brown R. Fungicidin, an antibiotic produced by a soil actinomycete. Proc Soc Exp Biol 1951; 76: 93.
   Web of Science ®Google Scholar
• Fushimi S, Nishikawa S, Shimazu A, Seto H. Studies on new phosphate ester antifungal antibiotics phoslactomycins. I. Taxonomy, fermentation, purification and biological activi-ties. J Antibiot 1989; 42 (7): 1019–25.
   Google Scholar
• Hanafi M, Shibata K, Ueki M, Taniguchi M. UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517–02. II. Structural elucidation. J Antibiot 1996; 49 (12): 1226–31.
   Google Scholar
• Fiedler HP, Nega M, Pfefferle C, Groth I, Kempter C, Stephan H, Metzger JW. Kanchanamycins, new polyol macrolide antibiotics produced by Streptomyces olivaceus Tu 4018. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot 1996; 49 (8): 758–64.
   Google Scholar
• Phay N, Yada H, Higashiyama T, Yokota A, Ichihara A, Tomita F. NP-101A, antifungal antibiotic from Strepto-myces aurantiogriseus NPO-101. J Antibiot 1996; 49 (7): 703–5.
   Web of Science ®Google Scholar
• Tanaka Y, Kanaya I, Takahashi Y, Shinose M, Tanaka H, Omura S. Phthoxazolin A, a specific inhibitor of cellulose biosynthesis from microbial origin. I. Discovery, taxonomy of producing microorganism, fermentation, and biological activity. J Antibiot 1993; 46 (8): 1208–13.
   Google Scholar
• Shiomi K, Arai N, Shinose M, Takahashi Y, Yoshida H, Iwabuchi J, Tanaka Y, Omura S. New antibiotics phthoxa-zolins B, C and D produced by Streptomyces sp. KO-7888. J Antibiot 1995; 48 (7): 714–9.
   Google Scholar
• Akeda Y, Shibata K, Ping X, Tanaka T, Taniguchi M. AKD-2A, B, C and D, new antibiotics from Streptomyces sp. OCU-42815. Taxonomy, fermentation, isolation, struc-ture elucidation and biological activity. J Antibiot 1995; 48 (5): 363–8.
   Google Scholar
• Hochlowski JE, Whittern DN, Hill P, McAlpine JB. Dor-rigocins: novel antifungal antibiotics that change the mor-phology of ras-transformed NIH/3T3 cells to that of normal cells. II. Isolation and elucidation of structures. J Antibiot 1994; 47 (8): 870–4.
   Google Scholar
• Mulks MH, Nair MG, Putnam AR. In vitro antibacterial activity of faeriefungin, a new broad-spectrum polyene macrolide antibiotic. Antimicrob Ag Chemother 1990; 34 (9): 1762–5.
   Google Scholar
• Urakawa A, Otani T, Yoshida K, Nakayama M, Suzukake-Tsuchiya K, Hon i M. Isolation, structure determination and biological activities of a novel antifungal antibiotic, S-632-C, closely related to glutarimide antibiotics. J Antibiot 1993; 46 (12): 1827–33.
   Google Scholar
• Singh S, Samanta TB. A121-an antifungal compound from Streptomyces species. Microbios 1992; 71(288-289): 217–24.
   Google Scholar
• Kotake C, Yamasaki T, Moriyama T, Shinoda M, Komiyama N, Furumai T, Konishi M, Oki T. Butyrolactols A and B, new antifungal antibiotics. Taxonomy, isolation, physico-chemical properties, structure and biological activ-ity. J Antibiot 1992; 45 (9): 1442–50.
   Google Scholar
• Losilla B, Pommier MT, Bonnaveiro N, Cremieux A, Michel G. Structure activity relationships of stendomycin, a lipopep-tide antibiotic from Streptomyces. Microbios 1992; 71(286): 75–80.
   Google Scholar
• Ohkuma H, Naruse N, Nishiyama Y, Tsuno T, Hoshino Y, Sawada Y, Konishi M, Oki T. Sultriecin, a new antifungal and antitumor antibiotic from Streptomyces roseiscleroticus. Production, isolation, structure and biological activity. J Antibiot 1992; 45 (8): 1239–49.
   Google Scholar
• Hakoda S, Tsubotani S, Iwasa T, Suzuki M, Kondo M, Harada S. Production and biological activities of a new antifungal antibiotic, TAN-950 A. J Antibiot 1992; 45 (6): 854–60.
   Web of Science ®Google Scholar
• Yamazaki M, Yamashita T, Harada T, Nishikiori T, Saito S, Shimada N, Fujii A. 44-Homooligomycins A and B, new antitumor antibiotics from Streptomyces bottropensis. Pro-ducing organism, fermentation, isolation, structure elucida-tion and biological properties. J Antibiot 1992; 45 (2): 171–9.
   Google Scholar
• Hochlowski JE, Mullally MM, Brill GM, Whittern DN, Buko AM, Hill P, McAlpine JB. Dunaimycins, a new com-plex of spiroketal 24-membered macrolides with immuno-suppressive activity. II. Isolation and elucidation of structures. J Antibiot 1991; 44 (12): 1318–30.
   Google Scholar
• Uramoto M, Kim CJ, Shin-Ya K, Kusakabe H, Isono K, Phillips DR, McCloskey JR. Isolation and characterization of phosmidosine. A new antifungal nucleotide antibiotic. J Antibiot 1991; 44 (4): 375–81.
   Google Scholar
• Iwamoto T, Tsujii E, Ezaki M, Fujie A, Hashimoto S, Okuhara M, Kohsaka M, Imanaka H, Kawabata K, In-amoto Y, et al. FR109615, a new antifungal antibiotic from Streptomyces setonii. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. J An-tibiot 1990; 43 (1): 1–7.
   Google Scholar
• Ryley JF, Wilson RG, Gravestock MB, Poysen JP. Experi-mental approaches to antifungal chemotherapy. Adv Phar-macol Chemother 1981; 18: 49–176.
   PubMedGoogle Scholar
• Yuan WM, Crawford DL. Characterization of Streptomyces lydicus WYEC108 as a potential biocontrol agent against fungal root and seed rots. Appl Env Microbiol 1995; 61(8): 3119–28.
   PubMed Web of Science ®Google Scholar
• Raytapadar S, Datta R, Paul AK. Effects of some heavy metals on growth, pigment and antibiotic production by Streptomyces galbus. Acta Microbiologica et Immunologica Hungarica 1995; 42 (2): 171–7.
   PubMedGoogle Scholar
• Tunac JB, Graham BD, Dobson WE, Lenzini MD. Novel antitumour antibiotics, CI-940 (PD 114,720) and PD 114,721. Taxonomy, fermentation and biological activity. J Antibiot 1985; 38 (4): 460–5.
   Google Scholar
• Hasegawa T, Kakushima M, Hatori M, Aburaki S, Kakinuma S, Furumai T. Pradimicins Ti and T2, new antifungal antibiotics produced by an actinomycete II. Structures and biosynthesis. J Antibiot 1993; 46 (4): 598–605.
   Web of Science ®Google Scholar
• Mukhopadhyay T, Vijayakumar EK, Nadkami SR, Sawant SN, Kenia J, Sachse B. 2-Demethylazalomycins F4a and F5a, two new antifungal metabolites from Actinomycete sp. HIL Y-9120362. J Antibiot 1995; 48 (11): 1350–2.
   Google Scholar
• Iakovleva EP, Omelchenko VN, Tsyganov VA, Shenin LD. New antibiotic, parvulomycin, produced by a culture of Actinomyces parvulus var. chromogenes var. nov. Antibiotiki 1976; 21(1): 38–40.
   Google Scholar
• Cidaria D, Borgonovi G, Pirali G. AB023, novel polyene antibiotics. I. Taxonomy of the producing organism, fermen-tation and antifungal activity. J Antibiot 1993; 46(2): 251–4.
   Google Scholar
• Garagulia AD, Orishchuk LF. Antifungal properties of the genus Mycobacterium. Mikrobiolohichnyi Zhurnal 1973; 35 (5): 648–50.
   Google Scholar
• Klich MA, Arthur KS, Lex AR, Bland JM. Burin A: a potential new fungicide for stored grains. Mycopathologia 1994; 127 (2): 123–7.
   Web of Science ®Google Scholar
• Besson F, Peypoux F, Michel G, Delcambe L. The structure of bacillomycin L, an antibiotic from Bacillus subtilis. Eu-ropean J Biochem 1977; 77 (1): 61–7.
   Web of Science ®Google Scholar
• Eshita SM, Roberto NH, Beale JM, Mamiya BM, Workman RF. Bacillomycin Lc, a new antibiotic of the iturin group: isolations, structures, and antifungal activities of the con-geners. J Antibiot 1995; 48 (H): 1240–7.
   Google Scholar
• Besson F, Michel G. Biosynthesis of bacillomycin D by Bacillus subtilis. Evidence for amino acid-activating enzymes by the use of affinity chromatography. FEBS Letters 1992; 308 (1): 18–21.
   Google Scholar
• Kajimura Y, Sugiyama M, Kaneda M. Bacillopeptins, new cyclic lipopeptide antibiotics from Bacillus subtilis FR-2. J Antibiot 1995; 48 (10): 1095–103.
   Web of Science ®Google Scholar
• Kugler M, Loeffler W, Rapp C, Kern A, Jung G. Rhizocticin A, an antifungal phosphono-oligopeptide of Bacillus subtilis ATCC 6633: biological properties. Arch Microbiol 1990; 153 (3): 276–81.
   Google Scholar
• Besson F, Michel G. Action of mycosubtilin, an antifungal antibiotic of Bacillus subtilis, on the cell membrane of Saccha - romyces cerevisiae. Microbios 1989; 59 (239): 113–21.
   Google Scholar
• Vanittanakom N, Loeffler W, Koch U, Jung G. Fengycin-a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J Antibiot 1986; 39 (7): 888–901.
   PubMed Web of Science ®Google Scholar
• Aoki Y, Kondoh M, Nakamura M, Fujii T, Yamazaki T, Shimada H, Arisawa M. A new methionine antigonist that has antifungal activity: mode of action. J Antibiot 1994; 47 (8): 909–16.
   Google Scholar
• Tschen JS, Tseng CN. Bacereutin, an antifungal antibiotic isolated from metabolites of Bacillus cereus CHU 130. Proc Natl Sci Council, PR China-Part B. Life Sciences. 1989; 13 (4): 258–61.
   Google Scholar
• Konishi M, Nishio M, Saitoh K, Miyaki T, Oki T, Kawaguchi H. Cispentacin, a new antifungal antibiotic. I. Production, isolation, physico-chemical properties and structure. J An-tibiot 1989; 42 (12): 1749–55.
   Google Scholar
• Wakayama S, Ishikawa F, Oishi K. Mycocerein, a novel antifungal peptide antibiotic produced by Bacillus cereus. Antimicrob Ag Chemother 1984; 26 (6): 939–40.
   Web of Science ®Google Scholar
• Lebbadi M, Galvez A, Maqueda M, Martinez-Bueno M, Valdivia E. Fungicidin M4: a narrow spectrum peptide antibiotic from Bacillus licheniformis M-4. J Appl Bacteriol 1994; 77 (1): 49–53.
   PubMed Web of Science ®Google Scholar
• Galvez A, Maqueda M, Martinez-Bueno M, Lebbadi M, Valdivia E. Isolation and physico-chemical characterisation of an antifungal and antibacterial peptide produced by Bacillus licheniformis Al2. Appl Microbiol Biotechnol 1993; 39 (4–5): 438–42.
   Google Scholar
• Sugawara T, Shibazaki M, Nakahara H, Suzuki K. YM-47522, a novel antifungal antibiotic produced by Bacillus sp. II. Structure and relative stereochemistry. J Antibiot 1996; 49 (4): 345–8.
   Google Scholar
• Lewis BA. Inhibition of Candida albicans by methanethiol produced by Brevibacterium linens. Microbiologica 1985; 8: 387–90.
   Google Scholar
• Collins EB, Hardt P. Inhibition of Candida albicans by Lactobacillus acidophilus. J Dairy Sci 1980; 63: 830–2.
   PubMed Web of Science ®Google Scholar
• Guillot N. Elaboration par Lactobacillus acidophilus d'un produit actif contre Candida albicans. Ann Inst Pasteur 1958; 95: 194–207.
   PubMedGoogle Scholar
• Mardh PA, Soltesz LV. In vitro interactions between lacto-bacilli and other microorganisms occurring in the vaginal flora. Scand J Infect Dis 1983; 40Suppl: 47–51.
   Google Scholar
• Young G, Resca RG, Sullivan MT. Interactions of oral strains of Candida and lactobacilli. J Bacteriol 1956; 72: 525–9.
   Web of Science ®Google Scholar
• Moore-Landecker E, Stotzky G. Inhibition of fungal growth and sporulation by volatile metabolites from bacteria. Can J Microbiol 1972; 18: 957–62.
   Google Scholar
• Moore-Landecker E, Stotzky G. Effects of concentration of volatile metabolites from bacteria and germinating seeds on fungi in the presence of selective absorbents. Can J Microbiol 1974; 20: 97–103.
   Google Scholar
• Kaczmarski W, Jakoniuk P, Borowski J. Effect of selected bacteria on mycelial transformation of cells of Candida albicans. Medycyna Doswiadczalna i Mikrobiologia 1989; 41 (3–4): 184–91.
   Google Scholar
• Kaczmarski W, Jakoniuk P, Borowski J. Isolation and iden-tification of the products of Streptococcus faecalis inhibition of mycelial transformation of Candida albicans. Medycyna Doswiadczalna i Mikrobiologia 1989; 41(3–4): 192–201.
   Google Scholar
• Auger P, Joly J. Study of some factors influencing the growth of Candida albicans in vitro. Mykosen 1978; 21: 63–70.
   Google Scholar
• Hummel RP, Malez MP, Miskell PW, Altemeier WA. Sup-pression of Candida albicans by Escherichia coli. J Trauma 1975; 15: 413–8.
   Google Scholar
• Isenberg HD, Pisano MA, Canto SL, Berkman JJ. Factors leading to overt monilial disease. I. Preliminary studies of the ecological relationship between Candida albicans and intesti-nal bacteria. Antibiot Chemother 1960; 10 (6): 353–63.
   Google Scholar
• Chernin L, Brandis A, Ismailov Z, Chet I. Pyrrolnitrin production by an Enterobacter agglomerans strain with a broad spectrum of antagonistic activity towards fungal and bacterial phytopathogens. Curr Microbiol 1996; 32: 208–12.
   Web of Science ®Google Scholar
• Gordee RS, Matthews TR. Evaluation of the in vitro and in vivo antifungal activity of pyrrolnitrin. Antimicrob Ag Chemother 1967; 7: 378–87.
   Google Scholar
• Greiner M, Winkelmann G. Fermentation and isolation of herbicolin A, a peptide antibiotic produced by Erwinia her-bicola strain A111. Appl Microbiol Biotechnol 1991; 34 (5): 565–9.
   Web of Science ®Google Scholar
• Winkelmann G, Lupp R, Jung G. Herbicolins-new peptide antibiotics from Erwinia herbicola. J Antibiot 1980; 33 (4): 353–8.
   Web of Science ®Google Scholar
• Shoji J, Hinoo H, Sakazaki R, Kato T, Hattori T, Matsumoto K, Tawara K, Kikuchi J, Terui Y. Isolation of CB-25-I, an antifungal antibiotic, from Serratia plymuthica. J Antibiot 1989; 42 (6): 869–74.
   Web of Science ®Google Scholar
• Kalbe C, Marten P, Berg G. Strains of the genus Serratia as beneficial rhizobacteria of oilseed rape with antifungal prop-erties. Microbiological Res 1996; 151 (4): 433–9.
   Google Scholar
• Serino L, Reimmann C, Visca P, Beyeler M, Chiesa VD, Haas D. Biosynthesis of pyochelin and dihydroaeruginoic acid requires the iron-regulated pchDCBA operon in Pseudomonas aeruginosa. J Bacteriol 1997; 179 (1): 248–57.
   PubMed Web of Science ®Google Scholar
• Carmi R, Carmeli S, Levy S, Gough FJ. S)-dihydroaeruginoic acid, an inhibitor of Septoria tritici and other phytopatho-genic fungi and bacteria, produced by Pseudomonas fluores-cans. J Natural Products 1994; 57 (9): 1200–5.
   PubMed Web of Science ®Google Scholar
• Kerr JR, Taylor GW, Rutman A, Hoiby N, Cole PJ, Wilson R. Pyocyanin inhibits yeast growth: a role in the prevention of pulmonary candidiasis. J Clin Pathol 1999; 52: 385–7.
   PubMed Web of Science ®Google Scholar
• Gaffney TD, Lam AT, Ligon J, Gates K, Frazelle A, Di Maio J, Hill S, Goodwin S, Torkewitz N, Allshouse AM, et al. Global regulation of expression of antifungal factors by a Pseudomonas fluorescens biological control strain. Molecular Plant-Microbe Interactions. 1994; 7 (4): 455–63.
   Web of Science ®Google Scholar
• Elander RP, Mabe JA, Hamill RH, Gorman M. Metabolism of tryptophans by Pseudomonas aureofaciens. VI. Production of pyrrolnitrin by selected Pseudomonas species. Appl Micro-biol 1968; 16 (5): 753–758.
   PubMedGoogle Scholar
• Vincent MN, Harrison LA, Brackin JM, Kovacevich PA, Mukerji P, Weller DM, Peirson EA. Genetic analysis of the antifungal activity of a soilborne Pseudomonas aureofaciens strain. Appl Env Microbiol 1991; 57 (10): 2928–34.
   PubMed Web of Science ®Google Scholar
• Harrison L, Teplow DB, Rinaldi M, Strobal G. Pseu-domycins, a family of novel peptides from Pseudomonas syringae possessing broad-spectrum antifungal activity. J Gen Microbiol 1991; 137 (12): 2857–65.
   Google Scholar
• Yamaguchi M, Park HJ, Ishizuka S, Omata K, Hirama M. Chemistry and antimicrobial activity of caryoynencins analogs. J Medicinal Chem 1995; 38 (26): 5015–22.
   Google Scholar
• Barker WR, Callaghan C, Hill L, Noble D, Acred P, Harper PB, Sowa MA, Fletton RA. G1549, a new cyclic hydroxamic acid antibiotic, isolated from culture broth of Pseudomonas akaligenes. J Antibiot 1979; 32 (11): 1096–103.
   PubMed Web of Science ®Google Scholar
• Walker R, Emslie KA, Allan EJ. Bioassay methods for the detection of antifungal activity by Pseudomonas ant imicrobica against the grey mould pathogen Botrytis cinerea. J Appl Bacteriol 1996; 81(5): 531–7.
   Google Scholar
• Spencer RC. The emergence of epidemic, multiple-antibiotic-resistant Steno trophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30Suppl: 453–64.
   Web of Science ®Google Scholar
• Lim Y, Suh JW, Kim S, Hyun B, Kim C, Lee CH. Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. II. Physico-chemical properties and structure elucida-tion. J Antibiot 1994; 47 (12): 1406–16.
   Google Scholar
• Abe M, Nakazawa T. Characterisation of haemolytic and antifungal substance, cepalycin, from Pseudomonas cepacia. Microbiol Immunol 1994; 38 (1): 1–9.
   PubMed Web of Science ®Google Scholar
• Jayaswal RK, Fernandez M, Upadhyay RS, Visintin L, Kurz M, Webb J, Rinehart K. Antagonism of Pseudomonas cepacia against phytopathogenic fungi. Current Microbiol 1993; 26 (1): 17–22.
   Web of Science ®Google Scholar
• Smirnov VV, Kiprianova EA, Garagulia AD, Dodatko TA, Pilishenko I. Antibiotic activity and siderophores of Pseu-domonas cepacia. II. Prikladnaia Biokhimiia i Mikrobiologiia 1990; 26 (1): 75–80.
   Google Scholar
• Bisacchi GS, Hockstein DR, Koster WH, Parker WL, Rath-num ML, Unger SE. Xylocandin: a new complex of antifun-gal peptides. II. Structural studies and chemical modifications. J Antibiot 1987; 40 (11): 1520–9.
   Google Scholar
• Moon SS, Kang PM, Park KS, Kim CH. Plant growth promoting and fungicidal 4-quinolones from Pseudomonas cepacia. Phytochemistry 1996; 42 (2): 365–8.
   Web of Science ®Google Scholar
• Kerr JR. Fungal growth suppression exhibited by Pseu-domonas aeruginosa and Pseudomonas cepacia isolates from cystic fibrosis patients. J Infect 1994; 28: 305–10.
   PubMed Web of Science ®Google Scholar
• Ferrer Marcelles A, Bellver Moreira P, Cobos Barroso N, Linan Cortes S, Codina Grau G, Fernandez Perez F. Cystic fibrosis: a microbiological study over an 8 year period. Archivos de Bronconeumologia 1995; 31(10): 494–500.
   Google Scholar
• Karpati F, Malmborg AS, Alfredsson H, Hjelte L, Strandvik B. Bacterial colonisation with Xanthomonas maltophilia-a retrospective study in a cystic fibrosis patient population. Infection 1994; 22: 258–63.
   Google Scholar
• Kerr JR. Inhibition of growth of fungi pathogenic to man by Stenotrophomonas maltophilia. J Med Microbiol 1996; 45: 380–2.
   Web of Science ®Google Scholar
• Jakobi M, Winkelmann G, Kaiser D, Kempler C, Jung G, Berg G, Bahl H. Maltophilin: a new antifungal compound produced by Stenotrophomonas maltophilia R3089. J Antibiot 1996; 49 (11): 1101–4.
   Web of Science ®Google Scholar
• Alnor D, Frimodt-Moller N, Espersen F, Frederiksen W. Infections with the unusual human pathogens Agrobacterium species and Ochrobactrum anthropi. Clinl Infect Dis 1994; 18 (6): 914–20.
   Web of Science ®Google Scholar
• Dunne Jr WM, Maisch S. Epidemioilogical investigation of infections due to Akaligenes species in children and patients with cystic fibrosis: use of repetitive element sequence poly-merase chain reaction. Clin Infect Dis 1995; 20 (4): 836–41.
   Web of Science ®Google Scholar
• Dolak LA, Castle TM, Hannon BR, Argoudelis AD, Reusser F. Fermentation, isolation, characterisation and structure of nitrosofungin. J Antibiot 1983; 36 (11): 1425–30.
   Google Scholar
• Pridachina NN, Novogrudskaia ED, Krugliak EB, Chekasina EV, Korchak TS. Azotobacter Chroococcum, a producer of a new antifungal antibiotic. Antibiotiki 1982; 27 (1): 3–6.
   Google Scholar
• Rosebury T, Gale D, Taylor DF. An approach to the study of interactive phenomena among micro-organisms indigenous to man. J Bacteriol 1954; 67: 135–52.
   Google Scholar
• Paine TF. In vitro experiments with monilia and Escherichia coli to explain moniliasis in patients receiving antibiotics. Antibiot Chemother 1952; 2: 653–8.
   Google Scholar
• Paine TF. The inhibiting actions of bacteria on Candida growth. Antibiot Chemother 1958; 8: 273–81.
   Google Scholar
• Sprunt K, Redman W. Evidence suggesting importance of role of interactive inhibition in maintaining balance of normal flora. Ann Intern Med 1968; 68: 579–90.
   PubMed Web of Science ®Google Scholar
• MacFarlane TW, Makrides HC. A new screening method for investigating microbial interactions. J Appl Bacteriol 1982; 52: 271–4.
   Google Scholar
• Arima K, Imanaka H, Kousaka M, Fukuta A, Tamura G. Pyrrolnitrin, a new antibiotic substance, produced by Pseu-domonas. Agric Biol Chem 1964; 28: 575–6.
   Web of Science ®Google Scholar
• Shenbagamurthi P, Smith HA, Becker JM, Steinfield A, Naider F. Design of anticandidal agents; synthesis and bio-logical properties of analogues of polyoxin L. J Med Chem 1983; 26: 1518–22.
   Google Scholar
• Plempel M. Pharmacokinetics of imidazole antimycotics. Postgrad Med J 1969; 55: 662.
   Google Scholar
• Alexander M. Introduction to soil microbiology, 2nd ed. 1977. John Wiley & Sons, New York.
   Google Scholar
• Becker JO, Schwinn FJ. Control of soil-borne pathogens with living bacteria and fungi: status and outlook. Pestic Sci 1993; 37: 355–63.
   Google Scholar
• Hill DS, Stein JI, Torlewitz NR, Morse AM, Howell CR, Pachlatko JP, Becker JO, Ligon JM. Cloning of genes involved in the synthesis of pyrrolnitrin from Pseudomonas fluorescens and role of pyrrolnitrin synthesis in biological control of plant disease. Appl Env Microbiol 1994; 60 (1): 78–85.
   PubMed Web of Science ®Google Scholar
• Thomashow LS, Weller DM. Role of a phenazine antibiotic from Pseudomonas fluorescens in biological control of Gaeu-mannomyces graminis var. tritici. J Bacteriol 1988; 170 (8): 3499–508.
   PubMed Web of Science ®Google Scholar
• Gurusiddaiah S, Weller DM, Sarkar A, Cook JR. Character-isation of an antibiotic produced by a strain of Pseudomonas fluorescens inhibitory to Gaeumannomyces graminis var tritici and Pythium spp. Antimicrob Ag Chemother 1986; 29 (3): 488–95.
   PubMed Web of Science ®Google Scholar
• McLoughlin TJ, Quinn JP, Bettermann A, Bookland R. Pseudomonas cepacia suppression of sunflower wilt fungus and role of antifungal compounds in controlling the disease. Appl Env Microbiol 1992; 58 (5): 1760–3.
   Web of Science ®Google Scholar
• Podile AR, Prakash AP. Lysis and biological control of Aspergillus niger by Bacillus subtilis AF1. Can J Microbiol 1996; 42: 533–8.
   PubMed Web of Science ®Google Scholar
• Helstrom PB, Balish F. Effect of oral tetracycline, the micro-bial flora and the athymic state on gastro-intestinal colonisa-tion and infection of BALB/c mice with Candida albicans. Infect Immun 1979; 23: 764–74.
   PubMed Web of Science ®Google Scholar
• Linsemark WF, Gibbons RJ. Suppression of Candida albi-cans by human oral streptococci in gnotobiotic mice. Infect Immun 1973; 8: 846–9.
   Web of Science ®Google Scholar
• Phillips AW, Balish E. Growth and invasiveness of Candida albicans in the germ-free and conventional mouse after oral challenge. Appl Microbiol 1966; 14: 737–41.
   PubMedGoogle Scholar
• Seelig MS. Mechanisms by which antibiotics increase the incidence and severity of Candidiasis and alter immunologi-cal defenses. Bacteriol Rev 1966; 30: 442–59.
   PubMedGoogle Scholar
• Kennedy MJ. Inhibition of Candida albicans by the anaero-bic oral flora of mice in vitro. Sabouraudia 1981; 19: 205–8.
   Google Scholar
• Odds FC. Factors that predispose the host to candidosis. 1988, p.93-104. In FC Odds (ed.), Candida and Candidosis, second edition. Bailliere Tindall, London, England.
   Google Scholar
• Govan JR, Nelson JW. Microbiology of lung infection in cystic fibrosis. Br Med Bull 1992; 48: 912–30.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Kim HK. Mycoflora in cystic fibrosis: some ecologic aspects of Pseudomonas aeruginosa and Candidaalbicans. Mycopathologia et Mycologia applicata 1973; 50: 261–9.
   Google Scholar
• Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, Cole PJ. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun 1988; 56: 2515–7.
   PubMed Web of Science ®Google Scholar
• Seidmon EJ, Mosovich LL, Neter E. Colonisation by Enter-obacteriaceae of the respiratory tract of children with cystic fibrosis of the pancreas and their antibody response. J Pediatr 1975; 87 (4): 528–33.
   Google Scholar
• Kerr JR. Fungal growth suppression exhibited by Pseu-domonas aeruginosa. J Clin Microbiol 1994; 32 (2): 525–7.
   PubMed Web of Science ®Google Scholar
• Odds FC. Candidosis of the genitalia. 1988, p.124-135. In FC Odds (ed.), Candida and Candidosis, second edition. Bailliere Tindall, London, England.
   Google Scholar
• Hanna E, Hughes G, Eliachar I, Wanamaker J, Tomford W. Fungal osteomyelitis of the temporal bone: a review of reported cases. Ear, Nose and Throat Journal 1993; 72 (8): 532–41.
   Google Scholar
• Brook I, Santosa G. Microbiology of chronic suppurative otitis media in children in Surabaya, Indonesia. Int J Pediatr Otorhinolaryngol 1995; 31(1): 23–8.
   Web of Science ®Google Scholar
• Dincer AD, Tekeli A, Ozturk S, Turgut S. Micro-organisms isolated from chronic suppurative otitis media and their antimicrobial sensitivities. Mikrobiyoloji Bulteni 1992; 26 (2): 131–8.
   Google Scholar
• Kerr JR. Fungal osteomyelitis of the temporal bone. Ear, Nose and Throat Journal 1994; 5: 222.
   Google Scholar
• Grillot R, Portmann-Coffin V, Ambroise-Thomas P. Growth inhibition of pathogenic yeasts by Pseudomonas aeruginosa in vitro: clinical implications in blood cultures. Mycoses 1994; 37: 343–7.
   PubMed Web of Science ®Google Scholar
• Hockey LJ, Fujita NK, Gibson TR, Rotrosen D, Mont-gomerie JZ, Edwards Jr JE. Detection of fungemia obscured by concomitant bacteremia: in vitro and in vivo studies. J Clin Microbiol 1982; 16 (6): 1080–5.
   Google Scholar